Use of alternative therapies in patients with dementia and mild cognitive impairment: a prospective, controlled study
✍ Scribed by Julia Landin; Lutz Frölich; Stefan Schwarz
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 59 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.2046
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Objectives
To study the frequency and type of alternative therapies used in patients with dementia and Mild Cognitive Impairment.
Methods
In a prospective study, 77 outpatients and 62 healthy volunteers were interviewed using a questionnaire concerning frequency, type and motivation of the use of alternative therapies.
Results
47% of patients and 18% of control subjects used alternative therapies to treat or prevent disturbances of memory (p < 0.001). No correlation could be found between use of alternative medicine and professional education, severity of disease, religion or health insurance status (p > 0.05). The most commonly used substances were vitamins. Side effects remained unreported. 52% of patients were treated with conventional medications. Only 44% of the patients informed their physician about the use of alternative medicine.
Conclusions
The use of alternative therapies, particularly vitamins, and herbal preparations of unknown efficacy is common among patients with dementia and MCI. Hence, the treating physician should actively inquire about their use as some preparations have pharmacological activity or could interact with other prescribed medications. Copyright © 2008 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract ## Objectives To assess the sensitivity of the ‘Alzheimer's Disease Related Quality of Life’ instrument (ADRQL) applied to Belgian people with dementia (__n__ = 357), mild cognitive impairment (MCI) (__n__ = 36), and controls (__n__ = 72). We also determined the clinical parameters tha
## Background: Several tests have been developed to examine performance of demented patients in daily life activities. however, most of them are based either on the subjective evaluation of performance by the patient him/herself, or on the reports of relatives. functional cognitive assessment scale
In several retrospective post-mortem studies, patients meeting clinical criteria for Alzheimer's disease (AD) who gained the greatest cognitive bene®t from treatment with an acetylcholinesterase (AChE) inhibitor were found to have neocortical Lewy bodies accompanying classical AD neuropathology. Thi
## Abstract ## Objective To assess combined antidepressant and cognitive enhancer treatment in elderly patients presenting with depression plus cognitive impairment. ## Methods Twenty‐three elderly (>50 years old) depressed, cognitively impaired (DEP‐CI) patients participated in a pilot study. W